Methylation of the p16(INK4A) gene in multiple myeloma

British Journal of Haematology

Volumn 101, Issue 3, 1998, Pages 558-564

  Tasaka, Taizo ^a   Asou, Hiroya ^a   Munker, Reinhold ^a   Said, Jonathan W ^a   Berenson, James ^a   Vescio, Robert A ^a   Nagai, Masami ^b   Takahara, Jiro ^b   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Cell cycle; Cyclin dependent kinase inhibitor; Methylation; Multiple myeloma; Tumour suppressor gene

Indexed keywords

DEOXYCYTIDINE; PROTEIN P16; PROTEIN P16INK4A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; METHYLATION; MULTIPLE MYELOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT PLANNING; TUMOR SUPPRESSOR GENE; CELL CULTURE; DISEASE COURSE; METABOLISM; METHODOLOGY; MIDDLE AGED; SOUTHERN BLOTTING;

AGED; BLOTTING, SOUTHERN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; MALE; METHYLATION; MIDDLE AGED; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0031595183     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00724.x     Document Type: Article

References (34)

1. Arap, W., Nishikawa, R., Furnari, F.B., Cavenee, W.K. & Huang, H.J. (1994) Replacement of the p1 6/CDKN2 gene suppresses human glioma cell growth. Cancer Research, 55, 1351-1354.
2. Bird, A. (1992) The essentials of DNA methylation. Cell, 70, 5-8.
3. Brenner, M.K., Rill, D.R., Moen, R.C., Krance, R.A., Mirro, J., Anderson. W.F. & Ihle, J.N. (1993) Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet, 341, 85-86.
4. INK4a/MTS1) gene structure and expression in acute lymphoblastic leukemia. Leukemia, 9, 1240-1245.
5. Fueyo, J., Gomez-Manzano, C., Bruner, J.M., Saito, Y., Zhang, B., Zhang, W., Levin, V.A., Yung, W.K. & Kyritsis, A.P. (1996) Hypermethylation of the CpG island of p1 6/CDKN2 correlates with gene inactivation in gliomas. Oncogene, 13, 1615-1619.
6. Gonzalez-Zulueta, M., Bender, C.M., Yang, A.S., Nguyen, T., Beart, R.W., Van Tornout, J.M. & Jones, P.A. (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Research, 55, 4531-4535.
7. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes and Development, 8, 2939-2952.
8. Hangaishi, A., Ogawa, S., Imamura, N., Miyawaki, S., Miura, Y., Uike, N., Shimazaki, C., Emi, N., Takeyama, K., Hirosawa, S., Kamada, N., Kobayashi, Y., Takemoto, Y., Kitani, T., Toyama, K., Ohtake, S., Yazaki, Y., Ueda, R. & Hirai, H. (1996) Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle. MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood, 87, 4949-4958.
9. Hatta, Y., Hirama, T., Miller, C.W., Yamada, Y., Tomonaga, M. & Koeffler, H.P. (1995) Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood, 85, 2699-2704.
10. Herman, J.G., Graff, J.R., Myohanen, S., Nelkin, B.D. & Baylin, S.B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proceedings of the National Academy of Sciences of the United States of America, 93, 9821-9826.
11. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P., Davidson, N.E., Sidransky, D. & Baylin, S.B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research. 55, 4525-4530.
12. Hirama, T. & Koeffler, H.P. (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86, 841-854.
13. Jagannath, S., Barogie, B., Dicke, K., Alexianian, R., Zagars, G., Cheson, B., Lemaistre, F.C., Smallwood, L., Pruitt, K. & Dixon, D.O. (1990) Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood, 76, 1860-1866.
14. Jones, P.A. (1996) DNA methylation errors and cancer. Cancer Research, 56, 2463-2467.
15. Koeffler, H.P. & Golde, D.W. (1978) Acute meylogenous leukemia: a human cell line responsible to colony-stimulating activity. Science, 200, 1153-1154.
16. Koh, J., Enders, G.H., Dynlacht, B.D. & Harlow, E. (1995) Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 375, 506-510.
17. Laird, P.W. & Jaenisch, R. (1994) DNA methylation and cancer. Human Molecular Genetics, 3, 1487-1496.
18. Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J., Strauss, M., Peters, G. & Bartek, J. (1995) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature, 75, 503-506.
19. Medema, R.H., Herrera, R.E., Lam, F. & Weinberg, R.A. (1995) Growth suppression by p16ink4 requires functional retinoblastoma protein. Proceedings of the National Academy of Sciences of the United States of America, 92, 6289-6293.
20. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. & Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine, 1, 686-692.
21. Nakamaki, T., Kawamata, N., Schwaller, J., Tobler, A., Fey, M., Pakkala, S., Lee, Y.Y., Kim, B.K., Fukuchu, K., Turuoka, N., Kahan, J., Miller, C.W. & Koeffler, H.P. (1995) Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. British Journal of Haematology, 91, 139-149.
22. Ng, M.H.L., Chung, Y.F., Lo, K.W., Wickman, N.W.R., Lee, J.C.K. & Huang, D.P. (1997) Frequent hypermethylation of the p16 and p15 genes in multiple myeloma. Blood, 89, 2500-2506.
23. Nishikawa, R., Furnari, F.B., Lin, H., Arap, W., Berger, M.S., Cavenee, W.K. & Su Huang, H.J. (1995) Loss of P16INK4 expression is frequent in high grade gliomas. Cancer Research, 55, 1941-1945.
24. Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., Shimazaki, C., Toyama, K., Hirano, M., Mizoguchi, H., Kobayashi, Y., Furusawa, S., Saito, M., Emi, N., Yazaki, Y. & Hirai, H. (1994) Loss of the cyclin-dependent kinase 4-inhibitor (p16: MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood, 86, 1548-56.
25. Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J.L., Bauters, F., Wattel, E. & Fenaux, P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85, 657-663.
26. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D.W., Rapaport, J.M. & Dryja, T.P. (1991) Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. American Journal of Human Genetics, 48, 880-886.
27. Schmidt, E.E., Ichimura, K., Reifenberger, G. & Collins, V.P. (1994) CDKN2 (p1 6/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Research, 54, 6321-6324.
28. Serrano, M., Hannon, G.J. & Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/ CDK 4. Nature, 366, 704-707.
29. Seto, M., Yamamoto, K., Iida, S., Akao, Y, Utsumi, K.R., Kubonishi, I., Miyoshi, I., Ohtsuki, T., Yawata, Y. & Namba, M. (1992) Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11:14)(q1 3;q32) translocation. Oncogene, 7, 1401-1406.
30. Shapiro, G.I., Park, J.E., Edwards, C.D., Mao, L., Merlo, A., Sidransky, D., Ewen, M.E. & Rollins, B.J. (1995) Multiple mechanisms of p1 6INK4A inactivation in non-small cell lung cancer cell lines. Cancer Research, 55, 6200-6209.
31. Stranks, G., Height, S.E., Mitchell, P., Jadayel, D., Yuille, M.A., De Lord, C., Clutterbuck, R.D., Treleaven, J.G., Powles, R.L. & Nacheva, E. (1995) Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood, 85, 893-901.
32. Takeuchi, S., Bartram, C.R., Seriu, T., Miller, C.W., Tobler, A., Jansse, J.W., Reiter, A., Ludwig, W.D., Zimmermann, M., Schwaller, J., Lee, E., Miyoshi, I. & Koeffler, H.P. (1995) Analysis of a family of cyclin-dependent kinase inhibitors: p1 5/MTS2/INK4B, p1 6/ MTS1/INK4A, and p1 8 genes in acute lymphoblastic leukemia of childhood. Blood, 86, 755-760.
33. Tasaka, T., Berenson, J., Vescio, R., Hirama, T., Miller, C.W., Nagai, M., Takahara, J. & Koeffler, H.P. (1997) Analysis of the p1 6INK4A, p1 5INK4B and p1 8INK4C genes in multiple myeloma. British Journal of Haematology, 96, 98-101.
34. Vesole, D.H., Barlogie, B., Jaganath, S., Cheson, B., Tricot, G., Alexianian, R. & Crowly, J. (1994) High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplant. Blood, 84. 950-956.